Q4 2024 · 13F-HR
BOONE CAPITAL MANAGEMENT LLCholdings as filed
Filed 2025-02-14 · accession 0001214659-25-002826
$296.5M
Reported value
13
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 91529Y106 | UNM | UNUM GROUP | $58.7M | 19.8% | 803,865 | Common | SOLE |
| 379577208 | GMED | GLOBUS MED INC | $47.0M | 15.9% | 568,465 | Common | SOLE |
| G97822103 | PRGO | PERRIGO CO PLC | $26.3M | 8.87% | 1,022,369 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $24.1M | 8.12% | 581,843 | Common | SOLE |
| 60855R100 | MOH | MOLINA HEALTHCARE INC | $23.8M | 8.03% | 81,842 | Common | SOLE |
| 125523100 | CI | THE CIGNA GROUP | $23.7M | 8.00% | 85,861 | Common | SOLE |
| 68752M108 | OFIX | ORTHOFIX MED INC | $18.5M | 6.23% | 1,057,313 | Common | SOLE |
| 70805E109 | PNTG | PENNANT GROUP INC | $17.0M | 5.74% | 641,255 | Common | SOLE |
| G1110E107 | BHVN | BIOHAVEN LTD | $13.5M | 4.55% | 361,420 | Common | SOLE |
| 45166A102 | IDYA | IDEAYA BIOSCIENCES INC | $13.5M | 4.55% | 524,868 | Common | SOLE |
| 46266C105 | IQV | IQVIA HLDGS INC | $11.2M | 3.79% | 57,141 | Common | SOLE |
| 37247D106 | GNW | GENWORTH FINL INC | $10.7M | 3.62% | 1,536,612 | Common | SOLE |
| 92686J106 | VKTX | VIKING THERAPEUTICS INC | $8.4M | 2.85% | 209,853 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.